This company has been marked as potentially delisted and may not be actively trading. NASDAQ:THRD Third Harmonic Bio (THRD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock About Third Harmonic Bio Stock (NASDAQ:THRD) 30 days 90 days 365 days Advanced Chart Get Third Harmonic Bio alerts:Sign Up Key Stats Today's Range$5.38▼$5.3850-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume247,013 shsMarket Capitalization$242.80 millionP/E RatioN/ADividend YieldN/APrice Target$5.00Consensus RatingHold Company Overview TF Financial Corporation is a savings and loan holding company. The Company's direct and indirect subsidiaries include Third Federal Bank (the Bank), Teragon Financial Corporation, Penns Trail Development Corporation and Third Delaware Corporation. The Bank is a community oriented Pennsylvania stock savings bank offering a variety of financial services to meet the needs of the communities it serves. As of December 31, 2011 the Bank operated fourteen branch offices in Bucks and Philadelphia Counties, Pennsylvania and in Mercer County, New Jersey. During the year ended December 31, 2011, the Company's subsidiary, TF Investments Corporation merged into TF Financial Corporation. In July 2013, the Company acquired Roebling Financial Corp, Inc. (Roebling) and its wholly-owned subsidiary, Roebling Bank. Read More Receive THRD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Third Harmonic Bio and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. THRD Stock News HeadlinesThird Harmonic Bio to Delist from NasdaqJuly 31, 2025 | tipranks.comThird Harmonic Bio, Inc. (THRD) Cash Flow - Yahoo FinanceJuly 11, 2025 | finance.yahoo.comBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.August 31 at 2:00 AM | Goldco Precious Metals (Ad)Third Harmonic Bio Stock (NASDAQ:THRD), Insider Trading ActivityJuly 11, 2025 | benzinga.comThird Harmonic Bio Inc News (THRD) - Investing.comJuly 3, 2025 | investing.comThird Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335June 12, 2025 | globenewswire.comNortheast Dominates 2025 Highest Income Rankings, Study Says: See Where Your State StandsJune 9, 2025 | msn.comThird Harmonic Bio plans to liquidate the company, sell urticaria treatmentApril 14, 2025 | msn.comSee More Headlines THRD Stock Analysis - Frequently Asked Questions How were Third Harmonic Bio's earnings last quarter? Third Harmonic Bio, Inc. (NASDAQ:THRD) announced its quarterly earnings data on Thursday, May, 8th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.09. When did Third Harmonic Bio IPO? Third Harmonic Bio (THRD) raised $185 million in an initial public offering on Thursday, September 15th 2022. The company issued 10,900,000 shares at a price of $16.00-$18.00 per share. Who are Third Harmonic Bio's major shareholders? Third Harmonic Bio's top institutional investors include TCG Crossover Management LLC (4.24%), Geode Capital Management LLC (1.28%), DLD Asset Management LP (1.12%) and OMERS ADMINISTRATION Corp (0.95%). Insiders that own company stock include Bvf Partners L P/Il, Natalie C Holles, Julie Person, Jennifer Dittman and Edward R Conner. View institutional ownership trends. What other stocks do shareholders of Third Harmonic Bio own? Based on aggregate information from My MarketBeat watchlists, some other companies that Third Harmonic Bio investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), ServiceNow (NOW) and e.l.f. Beauty (ELF). Company Calendar Last Earnings5/08/2025Today8/31/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryN/A Current SymbolNASDAQ:THRD CIK921051 Webwww.thirdfedbank.com Phone+1-215-5794000FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Price Target for Third Harmonic Bio$5.00 High Price Target$5.00 Low Price Target$5.00 Potential Upside/Downside-7.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$45.47 million Net MarginsN/A Pretax MarginN/A Return on Equity-19.27% Return on Assets-18.67% Debt Debt-to-Equity RatioN/A Current Ratio54.10 Quick Ratio54.10 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$6.33 per share Price / Book0.85Miscellaneous Outstanding Shares45,130,000Free Float41,608,000Market Cap$242.80 million OptionableOptionable Beta2.12 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:THRD) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Third Harmonic Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Third Harmonic Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.